We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Allograft Fibrosis Following Pediatric Cardiac Transplantation

This study has been terminated.
(unable to gather sufficient data)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00328185
First Posted: May 19, 2006
Last Update Posted: March 16, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Children's Healthcare of Atlanta
  Purpose
Transplantation is the preferred method of treating many forms of end-stage organ failure. While short-term results have improved, long-term outcomes remain inadequate. Myocardial fibrosis could potentially have an adverse effect on long-term cardiac function. We wish to study the degree of fibrosis to see if we can predict survival following pediatric heart transplantation.

Condition
Children Who Underwent Heart Transplantation Prior to Age 18 Received Care at Children's Healthcare of Atlanta

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Allograft Fibrosis: Its Regulation and Significance Following Pediatric Cardiac Transplantation

Resource links provided by NLM:


Further study details as provided by Children's Healthcare of Atlanta:

Enrollment: 100
Study Start Date: January 2006
Study Completion Date: December 2006
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children who underwent heart transplantation prior to age 18
Criteria

Inclusion Criteria:

  • Children who underwent heart transplantation prior to age 18
  • Followed up at Children's Healthcare of Atlanta

Exclusion Criteria:

  • Children without a transplanted heart
  • Follow-up not at children's Healthcare of Atlanta
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00328185


Locations
United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30329
Sponsors and Collaborators
Children's Healthcare of Atlanta
Investigators
Principal Investigator: Brian E Kogon, MD Emory University
  More Information

ClinicalTrials.gov Identifier: NCT00328185     History of Changes
Other Study ID Numbers: 05-217
First Submitted: May 18, 2006
First Posted: May 19, 2006
Last Update Posted: March 16, 2012
Last Verified: January 2006

Keywords provided by Children's Healthcare of Atlanta:
pediatric
heart disease
orthotopic heart transplantation
allograft fibrosis

Additional relevant MeSH terms:
Fibrosis
Pathologic Processes